Addex Pharmaceuticals - Financial and Strategic Analysis ReviewSummaryAddex Pharmaceuticals is a company engaged in discovery based development of allosteric modulators, small molecule therapeutic agents that offer more sophisticated ways to normalize biological signaling perturbed by disease. It is engaged into development of drug for the therapeutics areas like metabolic disorder, inflammation diseases and central nervous systems. The company has a pipeline of products in clinical or preclinical development for major market indications, including gastro esophageal reflux disease (GERD), migraine prevention, schizophrenia, contraception and Parkinson's disease. The company is headquarted in Geneva, Switzerland and employs 100 people as of March 2008.Global Markets Direct, the leading business information provider, presents an in-depth business, strategic and financial analysis of Addex Pharmaceuticals. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Markets Direct's views on the company.Scope-The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered. -The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted. -The report contains critical company information ' business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.-It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.-Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.Reasons to buy-A quick 'one-stop-shop' to understand the company. -Enhance business/sales activities by understanding customers' businesses better.-Get detailed information and financial & strategic analysis on companies operating in your industry.-Identify prospective partners and suppliers ' with key data on their businesses and locations.-Capitalize on competitors' weaknesses and target the market opportunities available to them.-Compare your company's financial trends with those of your peers / competitors.-Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Addex Pharmaceuticals - Financial and Strategic Analysis Review
Published on April 2009
Report Summary
Addex Pharmaceuticals - Financial and Strategic Analysis Review
Summary
Addex Pharmaceuticals is a company engaged in discovery based development of allosteric modulators, small molecule therapeutic
agents that offer more sophisticated ways to normalize biological signaling perturbed by disease. It is engaged into development of
drug for the therapeutics areas like metabolic disorder, inflammation diseases and central nervous systems. The company has a
pipeline of products in clinical or preclinical development for major market indications, including gastro esophageal reflux disease
(GERD), migraine prevention, schizophrenia, contraception and Parkinson's disease. The company is headquarted in Geneva,
Switzerland and employs 100 people as of March 2008.
Global Markets Direct, the leading business information provider, presents an in-depth business, strategic and financial analysis of
Addex Pharmaceuticals. The report provides a comprehensive insight into the company, including business structure and operations,
executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Markets Direct's
views on the company.
Scope
-The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational
factors are considered.
-The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are
highlighted.
-The report contains critical company information ' business structure and operations, the company history, major products and
services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
-It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
-Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
-A quick 'one-stop-shop' to understand the company.
-Enhance business/sales activities by understanding customers' businesses better.
-Get detailed information and financial & strategic analysis on companies operating in your industry.
-Identify prospective partners and suppliers ' with key data on their businesses and locations.
-Capitalize on competitors' weaknesses and target the market opportunities available to them.
-Compare your company's financial trends with those of your peers / competitors.
-Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Addex Pharmaceuticals - Financial and Strategic Analysis Review Page 1/5

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Table of Content
Table Of Contents
Key Information 1
Key Ratios 1
Share Data 1
Performance Chart 1
Table Of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Business Description 4
Major Products and Services 5
Overview 5
History 5
SWOT Analysis Overview 6
Overview 6
Addex Pharmaceuticals - Strengths 6
Allosteric Modulators 6
Extensive Research Operations 6
Addex Pharmaceuticals - Weaknesses 6
Difficulty in Obtaining Funds 6
Decline in Revenues 6
Addex Pharmaceuticals - Opportunities 6
Effective Drug for Migraine Prevention 6
Successful Deal with Merck Inc 7
Addex Pharmaceuticals - Threats 7
Unexpected Results of Clinical Trials 7
Competition 7
Stringent Regulatory Actions 7
Key Employees 8
Key Employee Biographies 9
Company Statement 10
Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Financial Ratios 12
Capital Market Ratios 12
Annual Ratios 12
Interim Ratios 13
Ratio Charts 14
Appendix 15
Methodology 15
Ratio Definitions 15
About Global Markets Direct 18
Contact Us 18
Disclaimer 18List of Tables
Addex Pharmaceuticals, Key Facts 1
Addex Pharmaceuticals - Financial and Strategic Analysis Review Page 2/5

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Addex Pharmaceuticals, Key Ratios 1
Addex Pharmaceuticals, Share Data 1
Addex Pharmaceuticals, Key Facts 4
Major Products and Services 5
Addex Pharmaceuticals, History 5
Addex Pharmaceuticals, Key Employees 8
Addex Pharmaceuticals, Key Employee Biographies 9
Addex Pharmaceuticals, Subsidiaries 11
Addex Pharmaceuticals, Ratios based on current share price 12
Addex Pharmaceuticals, Annual Ratios 12
Addex Pharmaceuticals, Interim Ratios 13
Currency Codes 15
Capital Market Ratios 15
Equity Ratios 15
Profitability Ratios 16
Cost Ratios 16
Liquidity Ratios 16
Leverage Ratios 17
Efficiency Ratios 17List of Figures
Addex Pharmaceuticals, Performance Chart (2004 - 2008) 1
Addex Pharmaceuticals, Ratio Charts 14
Addex Pharmaceuticals - Financial and Strategic Analysis Review Page 3/5

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Addex Pharmaceuticals - Financial and Strategic Analysis Review
Product Formats
Please select the product formats and the quantity you require.
Digital Copy--USD 125.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Addex Pharmaceuticals - Financial and Strategic Analysis Review Page 4/5

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Addex Pharmaceuticals - Financial and Strategic Analysis Review Page 5/5